If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nicoletta Zilembo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 79 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy

Galli, G., Proto, C., Signorelli, D., Imbimbo, M., Ferrara, R., Prelaj, A., De Toma, A., Ganzinelli, M., Zilembo, N., De Braud, F., Garassino, M. C. & Lo Russo, G., Aug 2019, In : Future Oncology. 15, 23, p. 2743-2757 15 p.

Research output: Contribution to journalArticle

  • Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

    Proto, C., Ferrara, R., Signorelli, D., Lo Russo, G., Galli, G., Imbimbo, M., Prelaj, A., Zilembo, N., Ganzinelli, M., Pallavicini, L. M., De Simone, I., Colombo, M. P., Sica, A., Torri, V. & Garassino, M. C., May 2019, In : Cancer Treatment Reviews. 75, p. 39-51 13 p.

    Research output: Contribution to journalReview article

  • Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

    Proto, C., Ferrara, R., Signorelli, D., Lo Russo, G., Galli, G., Imbimbo, M., Prelaj, A., Zilembo, N., Ganzinelli, M., Pallavicini, L. M., De Simone, I., Colombo, M. P., Sica, A., Torri, V. & Garassino, M. C., May 2019, In : Cancer Treatment Reviews. 75, p. 39-51 13 p.

    Research output: Contribution to journalArticle

  • Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer

    Galli, G., De Toma, A., Pagani, F., Randon, G., Trevisan, B., Prelaj, A., Ferrara, R., Proto, C., Signorelli, D., Ganzinelli, M., Zilembo, N., de Braud, F., Garassino, M. C. & Lo Russo, G., Nov 2019, In : Lung Cancer. 137, p. 38-42 5 p.

    Research output: Contribution to journalArticle

  • Epsilon: A prognostic score for immunotherapy in advanced non-small-cell lung cancer: A validation cohort

    Prelaj, A., Ferrara, R., Rebuzzi, S. E., Proto, C., Signorelli, D., Galli, G., De Toma, A., Randon, G., Pagani, F., Viscardi, G., Brambilla, M., Trevisan, B., Ganzinelli, M., Martinetti, A., Gallucci, R., Di Mauro, R. M., Molino, G., Zilembo, N., Torri, V., de Braud, F. M. & 2 others, Garassino, M. C. & Lo Russo, G., Dec 2019, In : Cancers. 11, 12, 1954.

    Research output: Contribution to journalArticle

    Open Access